Trial Profile
A 6-Week, Randomized, Double-Blind, Parallel-Group Study To Evaluate The Symptomatic Effects And Safety Of Celecoxib 200mg QD Compared To Diclofenac 75mg SR QD In Chinese Patients With Ankylosing Spondylitis, With 6-Week Extension Phase Treatment On Celecoxib 400 Mg QD Or Maintaining Double-Blind Phase Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Diclofenac
- Indications Ankylosing spondylitis; Musculoskeletal pain
- Focus Therapeutic Use
- 13 Aug 2010 Actual end date (August 2010) added as reported by ClinicalTrials.gov.
- 13 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2010 Planned end date changed from 1 Jun 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.